Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals

NCT04349228 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped \- Interest in the use of HCQ is controversial.

Conditions

COVID19
Sars-CoV2
Hydroxychloroquine
Prophylaxis
Healthcare Worker

Interventions

DRUG: Hydroxychloroquine (HCQ)
DRUG: Placebo oral tablet

Sponsor

Abderrahmane Mami Hospital

Collaborators

[object Object]
[object Object]